
About AtriCure
AtriCure is a publicly listed company based in Mason (United States) founded in 2000. Cardiac ablation and occlusion devices for atrial fibrillation are provided. The company has 1,300 employees. AtriCure has completed 4 acquisitions, including Estech, SentreHEART and nContact. Its website atricure.com draws about 18 thousand monthly visits. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Similar companies include AtaCor Medical, Kestra Medical Technologies and CardioFocus; 3 of its 3 listed similar companies have raised funding.
Company details
AtriCure was founded in 2000 and is headquartered in Mason, United States. Products focused on cardiac surgery, such as ablation devices, left atrial appendage occlusion tools, and intraoperative testing equipment, are offered in the medical device sector. The company was taken public in 2005. In October 2015, nContact, a developer of ablation solutions, was acquired to expand capabilities. Operations center on therapies for atrial fibrillation.
- Headquarters Mason, United States
- Employees 1,300
- Stage Public
- SectorsHealthcare
- Website atricure.com
- Social LinkedIn X Facebook YouTube
- Legal Name Atricure, Inc.
- Annual Revenue$534.53 M (USD)14.88as on Dec 31, 2025
- Net Profit-$11.45 M (USD)74.39as on Dec 31, 2025
- EBITDA$17.08 M (USD)as on Dec 31, 2025
- Employee Count1,300
- Investments & AcquisitionsEstech
& 3 more
Apps and channels of AtriCure
its YouTube channel AtriCure, Inc. has 1.17K subscribers and 30 videos.
Videos from AtriCure
The most watched videos on AtriCure's YouTube channel, AtriCure, Inc. (1.17K subscribers). Click a video to play it here.
More on AtriCure, Inc..
People of AtriCure
161 people are tracked at AtriCure (70 in leadership, 8 in board & advisors, 83 in team); the tracked headcount is 1,300.
| Name | Role | Group |
|---|---|---|
Angela L. Wirick | Chief Financial Officer | Leadership |
Douglas J. Seith | Chief Operating Officer | Leadership |
Karl Dahlquist | Chief Legal Officer | Leadership |
Sam Privitera | Chief Technical Officer | Leadership |
A K Masud | Vice President, Asia Pacific And Greater China | Leadership |
Doug Seith | Chief Operating Officer | Leadership |
Wendy Trevil | Senior Director, Diversity, Equity And Inclusion | Leadership |
Rebecca Anderson | Senior Director Product Marketing | Leadership |
Tim McGill | Sr. Director Of Marketing, Left Atrial Appendage Management | Leadership |
Michael H. Carrel | President And Chief Executive Officer | Leadership |
Pete Schweikle | Senior Director GSS | Leadership |
Paul Ahlemeyer | Senior Director Of Marketing | Leadership |
Matt Halasy | Director Of Global Sales Planning | Leadership |
Craig Sander | Principal Talent Development Partner | Leadership |
Justin Noznesky | Chief Marketing & Strategy Officer | Leadership |
Vini Doraiswamy | Chief Scientific Officer | Leadership |
Michael Balger | Vice President Of Sales | Cryo Nerve Block | Leadership |
Gina Martin | Sr. Director Sales Support, U.s. Asia And Americas | Leadership |
Barrett Ethridge | Area Director - Hybrid Therapies Southwest | Leadership |
Elizabeth Barnes | Senior Director, R&d | Leadership |
141 more people are available in the full profile.
Complete people profiles for AtriCure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of AtriCure
AtriCure is a publicly listed company on the NASDAQ with ticker symbol ATRC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Aug 2005
- Listed onNASDAQ: ATRC
- Listed entityAtriCure, Inc.
- Exchange sectorHealth technology
- ISINUS04963C2098
- Share price$56.87 (-0.72% on the day) · 2026-10-13
- Market capitalisation$2.89B
- Price to earnings262.7
- EPS (diluted, trailing year)$0.22
- Volume (last session)596,098
Financials of AtriCure
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $534.5M | -$11.4M | $17.1M |
| 2024 | $465.3M | -$44.7M | -$9.3M |
| 2023 | $399.2M | -$30.4M | -$16.3M |
| 2022 | $330.4M | -$46.5M | -$31.0M |
| 2021 | $274.3M | $50.2M | -$36.9M |
Detailed financial statements for AtriCure
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AtriCure
AtriCure has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Estech, SentreHEART and nContact.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Suture-based devices for soft tissue closure are developed. | sentreheart.com | Redwood, United States | 2005 | Aug 2019 | •••• | |
Cardiac ablation devices for atrial fibrillation treatment are developed. | ncontactsurgical.com | Morrisville, United States | 2005 | Oct 2015 | $99M | |
Epicardial ablation devices | ncontact.us | Morrisville, United States | 2005 | Oct 2015 | •••• | |
RF ablation devices for atrial fibrillation treatment are provided. | estech.com | San Ramon, United States | 1996 | Dec 2013 | •••• |
Complete acquisition details for AtriCure
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of AtriCure
6 dated milestones of AtriCure across 19 years, from founding to its latest funding, stage changes and deals.
- Founded AtriCure is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Estech.
- Acquisition Acquires nContact.
- Acquisition Acquires nContact Surgical.
- Acquisition Acquires SentreHEART.
Similar companies to AtriCure
AtriCure has 3 listed similar companies in our database, 3 of them funded. They include AtaCor Medical, Kestra Medical Technologies and CardioFocus.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atacor.com | 2014 | San Clemente, United States | $136.8M | 15 | An implantable pacemaker system is developed for cardiac pacing therapy. | |
| kestramedical.com | 2014 | Kirkland, United States | $196M | 118 | Medical devices are developed to support cardiovascular patients at risk. | |
| cardiofocus.com | 1990 | Marlborough, United States | $260.86M | 105 | Endoscopic catheter for atrial fibrillation ablation is developed. |
Detailed similar companies of AtriCure
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AtriCure
The website of AtriCure (atricure.com) receives about 18.2K visits a month.
- Monthly visits18.2K
▼ 9.4% vs previous month
Websites whose visitors overlap most with AtriCure. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medtronic.com | 100% | 2.6M | #22,622 | View details | |
| sjm.com | 99% | 1.2K | #13,629,967 | View details | |
| cardiokinetix.com | 83% | View details | |||
| arrowintl.com | 74% | View details | |||
| sorin.com | 74% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for AtriCure
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as AtriCure (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Atricure
Complete news archive for AtriCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AtriCure
AtriCure was founded in 2000.
AtriCure is headquartered in Mason, United States. It is registered at Mason, Ohio, United States.
AtriCure has 1,300 employees.
Annual revenue of AtriCure is $534.53M as on Dec 31, 2025.
AtriCure was founded in 2000 and is headquartered in Mason, United States. Products focused on cardiac surgery, such as ablation devices, left atrial appendage occlusion tools, and intraoperative testing equipment, are offered in the medical device sector. The company was taken public in 2005. In October 2015, nContact, a developer of ablation solutions, was acquired to expand capabilities. Operations center on therapies for atrial fibrillation.
AtriCure's top competitors include AtaCor Medical, CardioFocus and Kestra Medical Technologies.
Yes, AtriCure is publicly traded on NASDAQ under the ticker symbol ATRC.
AtriCure has made 4 acquisitions, including Estech, SentreHEART, and nContact.
